AI assistant
Sending…
AbbVie Inc. — Director's Dealing 2021
Dec 8, 2021
29755_dirs_2021-12-08_a642174c-f598-43af-adad-97b8d395e066.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-12-06
Reporting Person: RICHMOND TIMOTHY J. (EVP, Chief HR Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-06 | Common Stock, $0.01 par value | M | 50350 | $58.88 | Acquired | 50350 | Direct |
| 2021-12-06 | Common Stock, $0.01 par value | S | 50350 | $120 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-12-06 | Option (Right to buy) | $58.88 | M | 50350 | Disposed | 2025-02-18 | Common stock (50350) | Direct |
Footnotes
F1: Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
More from AbbVie Inc.
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 12
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 29
Capital/Financing Update
2026
Apr 3
Major Shareholding Notification
2026
Mar 26
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Capital/Financing Update
2026
Mar 4
Director's Dealing
2026
Mar 4